Back
New York Times Vs. Novo Nordisk AS Industry Stock Comparison
Buy
57
NYT
New York Times
Last Price:
$52.87
Seasonality Move:
6.36%
Sell
13
NONOF
Novo Nordisk AS
Last Price:
$84.75
Seasonality Move:
6.94%
Buy
57
New York Times (NYT)
is a Buy
Is New York Times a Buy, Sell or Hold?
-
The current New York Times [NYT] share price is $52.87. The Score for NYT is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
NYT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
13
Novo Nordisk AS (NONOF)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NONOF] share price is $84.75. The Score for NONOF is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
-
NONOF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
NYT Stock Price Chart
What is New York Times's stock price today?
-
The New York Times share price today is $52.87Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NYT is experiencing selling pressure, which indicates risk of future bearish movement.
NONOF Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $84.75Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing buying pressure, which is a positive indicator for future bullish movement.
NYT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.21 | Sell |
Relative Strength Index (14 RSI): | 39.97 | Sell |
Chaikin Money Flow: | -2610197 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (52.98 - 55.46) | Sell |
Bollinger Bands (100): | (53.35 - 55.63) | Sell |
NONOF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.51 | Sell |
Relative Strength Index (14 RSI): | 24.55 | Sell |
Chaikin Money Flow: | 64911 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (100.57 - 111.43) | Sell |
Bollinger Bands (100): | (107.18 - 131.16) | Sell |
NYT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 54.37 | Sell |
20-day SMA: | 54.66 | Sell |
50-day SMA: | 54.7 | Sell |
200-day SMA: | 51.12 | Buy |
8-day EMA: | 54.03 | Sell |
20-day EMA: | 54.42 | Sell |
50-day EMA: | 54.49 | Sell |
200-day EMA: | 51.69 | Buy |
NONOF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 105.03 | Sell |
20-day SMA: | 106.85 | Sell |
50-day SMA: | 109.33 | Sell |
200-day SMA: | 126.14 | Sell |
8-day EMA: | 102.09 | Sell |
20-day EMA: | 105.65 | Sell |
50-day EMA: | 110.06 | Sell |
200-day EMA: | 118.01 | Sell |
New York Times Earnings Growth & NYT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.39 per share, and an increase next year of $0.19 per share.
Novo Nordisk AS Earnings Growth & NONOF Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and an increase next year of $0.55 per share.
New York Times Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novo Nordisk AS Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |